NT Mobile Menu



AAN 2016

This year's American Academy of Neurology annual meeting takes place April 15-21, 2016 in Vancouver, British Columbia.


Recent Content

Neurologic conditions, such as epilepsy, migraine, and stroke, often have real-world consequences, such as those described in three new studies.

Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.

How do you approach the management of patients with multiple sclerosis and another autoimmune condition, such as psoriasis?

A retrospective cohort study of Medicare patients sought to determine if carotid endarterectomy or carotid stenting provided better outcomes.

Nuplazid, which the FDA designated as a breakthrough therapy and granted priority review, could help approximately 50% of Parkinson patients.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

From no evidence of disease activity in MS to studies of a new treatment for periodic paralysis, AAN 2016 featured many exciting clinical trials.

By clicking Accept, you agree to become a member of the UBM Medica Community.